Skip to main content
Log in

Stroke-Induced Peripheral Immune Dysfunction in Vitamin D–Deficient Conditions: Modulation by Progesterone and Vitamin D

  • Published:
Molecular Neurobiology Aims and scope Submit manuscript

Abstract

Vitamin D deficiency (Ddef) alters morphology and outcomes after a stroke. We investigated the interaction of Ddef following post-stroke systemic inflammation and evaluated whether administration of progesterone (P) or vitamin D (D) will improve outcomes. Ddef rats underwent stroke with lipopolysaccharide (LPS)-induced systemic inflammation. Rats were randomly divided into 9 groups and treated with P, D, or vehicle for 4 days. At day 4, rats were tested on different behavioral parameters. Markers of neuronal inflammation, endoplasmic reticulum stress, oxidative stress, white matter integrity, and apoptosis were measured along with immune cell populations from the spleen, thymus, and blood. Severely altered outcomes were observed in the Ddef group compared to the D-sufficient (Dsuf) group. Stroke caused peripheral immune dysfunction in the Dsuf group which was worse in the Ddef group. Systemic inflammation exacerbated injury outcomes in the Dsuf group and these were worse in the Ddef group. Monotherapy with P/D showed beneficial functional effects but the combined treatment showed better outcomes than either alone. Ddef as a comorbid condition with stroke worsens stroke outcomes and can delay functional recovery. Combination treatment with P and D might be promising for future stroke therapeutics in Ddef.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Benjamin EJ, Blaha MJ, Chiuve SE et al (2017) Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation 135:e646–e603

    Article  Google Scholar 

  2. Tsivgoulis G, Alexandrov AV (2014) Does “time is brain” also mean “time is clot”? time dependency of tissue-type plasminogen activator–induced recanalization in acute ischemic stroke. 45:2555–2556

  3. Kim K, Cho KH, Im SH, Choi J, Yu J, Kim MY (2017) Decrement of serum vitamin D level after stroke. Ann Rehabil Med 41:944–950

    Article  Google Scholar 

  4. Pfotenhauer KM, Shubrook JH (2017) Vitamin D deficiency, its role in health and disease, and current supplementation recommendations. Evid Based Clin Rev 111:301–305

    Google Scholar 

  5. Sizar O, Khare S, Goyal A, et al. (2020) Vitamin D deficiency. [Updated 2020 Jul 4]. In: StatPearls. Treasure Island (FL): StatPearls Publishing; Available from: https://www.ncbi.nlm.nih.gov/books/NBK532266/

  6. Mastroeni SS, Munasinghe LL, Pham TM et al (2016) The effect of serum 25-hydroxyvitamin D concentrations on elevated serum C-reactive protein concentrations in normal weight, overweight and obese participants of a preventive health program. Nutrients 8:696

  7. Sassi F, Tamone C et al (2018) Vitamin D: nutrient, hormone, and immunomodulator. Nutrients 3:10

  8. Di Somma C, Scarano E, Barrea L et al (2017) Vitamin D and neurological diseases: an endocrine view. Int J Mol Sci 18:e2482

  9. Hu W, Liu D, Li Q, Wang L, Tang Q, Wang G (2019) Decreasing serum 25-hydroxyvitamin D levels and risk of early neurological deterioration in patients with ischemic stroke. Brain Behav 9:e01227

    Article  Google Scholar 

  10. Fanari Z, Hammami S, Hammami MB, Hammami S, Abdellatif A (2015) Vitamin D deficiency plays an important role in cardiac disease and affects patient outcome: Still a myth or a fact that needs exploration? J Saudi Heart Assoc 27:264–271

    Article  Google Scholar 

  11. Fahmy E, Sharaf S, Helmy H et al (2019) Vitamin D status in acute ischemic stroke: relation to initial severity and short-term outcome. The Egyptian Journal of Neurology, Psychiatry and. Neurosurgery 55:18

    Google Scholar 

  12. Balden R, Selvaman A, Sohrabji F (2012) Vitamin D deficiency exacerbates experimental stroke injury and dysregulates ischemia-induced inflammation in adult rats. Endocrinology 153:2420–2435

    Article  CAS  Google Scholar 

  13. Turetsky A, Goddeau RP, Henninger N (2015) Low serum vitamin D is independently associated with larger lesion volumes after ischemic stroke. J Stroke Cerebrovasc Dis 24:1555–1563

  14. Park KY, Chung PW, Kim YB, Moon HS, Suh BC, Won YS, Kim JM, Youn YC et al (2015) Serum Vitamin D status as a predictor of prognosis in patients with acute ischemic stroke. Cerebrovasc Dis 40:73–80

  15. Daumas A, Daubail B, Legris N, Jacquin-Piques A, Sensenbrenner B, Denimal D, Lemaire-Ewing S, Duvillard L et al (2016) Association between admission serum 25-hydroxyvitamin D levels and functional outcome of thrombolyzed stroke patients. J Stroke Cerebrovasc Dis 25:907–913

  16. Nie Z, Ji X-C, Wang J, Zhang H-X (2017) Serum levels of 25-hydroxyvitamin D predicts infarct volume and mortality in ischemic stroke patients. J Neuroimmunol 313:41–5

  17. Zhang B, Wang Y, Zhong Y, Liao S, Lu Z (2018) Serum 25-hydroxyvitamin D deficiency predicts poor outcome among acute ischemic stroke patients without hypertension. Neurochem Int 118:91–5

  18. Narasimhan S, Balasubramanian P (2017) Role of vitamin D in the outcome of ischemic stroke- A randomized controlled trial. Clin Diagn Res 11:CC06-CC10

  19. Alfieri DF, Lehmann MF, Oliveira SR, Flauzino T, Delongui F, de Araújo MCM et al (2017) Vitamin D deficiency is associated with acute ischemic stroke, C-reactive protein, and short-term outcome. Metab Brain Dis 32:493–502

  20. Wang Q, Zhu Z, Liu Y et al (2018) Relationship between serum vitamin D levels and inflammatory markers in acute stroke patients. Brain Behav 8:e00885

  21. Chen H, Liu Y, Huang G, Zhu J, Feng W, He J (2018) Association between vitamin D status and cognitive impairment in acute ischemic stroke patients: a prospective cohort study. Clin Interv Aging 13:2503–9–250

  22. Chung PW, Park KY, Jeong M et al (2015) 25-Hydroxyvitamin D status is associated with chronic cerebral small vessel disease. Stroke 46:248–251–250

  23. Pilz S, Tomaschitz A, März W et al (2011) Vitamin D, cardiovascular disease and mortality. Clin Endocrinol (Oxf) 75:575-584

  24. Wei ZN, Kuang JG (2018) Vitamin D deficiency in relation to the poor functional outcomes in nondiabetic patients with ischemic stroke. Biosci Rep 38:BSR20171509

  25. Zhou R, Wang M, Huang H, Li W, Hu Y, Wu T (2018) Lower vitamin D status is associated with an increased risk of ischemic stroke: a systematic review and meta-analysis. Nutrients 10:277

  26. Stein DG (2013) A clinical/translational perspective: can a developmental hormone play a role in the treatment of traumatic brain injury? Horm Behav 63(2):291-250–300

  27. Atif F, Yousuf S, Sayeed I et al (2013) Combination treatment with progesterone and vitamin D hormone is more effective than monotherapy in ischemic stroke: the role of BDNF/TrkB/Erk1/2 signaling in neuroprotection. Neuropharmacology 67:78–87

  28. Yousuf S, Atif F, Sayeed I (2013) Post-stroke infections exacerbate ischemic brain injury in middle-aged rats: immunomodulation and neuroprotection by progesterone. Neuroscience 239:92–102

  29. Yousuf S, Atif F, Sayeed I (2014a) Progesterone in transient ischemic stroke: a dose-response study. Psychopharmacology 231:3313–3323

  30. Yousuf S, Sayeed I, Atif F (2014b) Delayed progesterone treatment reduces brain infarction and improves functional outcomes following ischemic stroke: a time-window study. J Cereb Blood Flow Metab 34:297–306

  31. Wong R, Gibson CL, Kendall DA (2014) Evaluating the translational potential of progesterone treatment following transient cerebral ischaemia in male mice. BMC Neurosci 29:131

  32. Vonder Haar C, Peterson TC, Martens KM, Hoane MR (2016) Vitamins and nutrients as primary treatments in experimental brain injury: clinical implications for nutraceutical therapies. Brain Res 1640(Pt A):114–129

  33. Jamall OA, Feeney C, Zaw-Linn J et al (2016) Prevalence and correlates of vitamin D deficiency in adults after traumatic brain injury. Clin Endocrinol (Oxf) 85(4):636–644

  34. Kaur J, Ferguson SL, Freitas E et al (2019) Association of vitamin D status with chronic disease risk factors and cognitive dysfunction in 50-70 year old adults. Nutrients 11(1):141

  35. Cekic M, Sayeed I, Stein DG (2009) Combination treatment with progesterone and vitamin D hormone may be more effective than monotherapy for nervous system injuAtifry and disease. Front Neuroendocrinol 30:158–172

  36. Cekic M, Cutler SM, VanLandingham JW et al (2011) Vitamin D deficiency reduces the benefits of progesterone treatment after brain injury in aged rats. Neurobiol Aging 32:864–874

  37. Atif F, Sayeed I, Ishrat T et al (2009) Progesterone with vitamin D affords better neuroprotection against excitotoxicity in cultured cortical neurons than progesterone alone. Mol Med 15:328–36

  38. Tang H, Hua F, Wang J et al (2015) Progesterone and vitamin D combination therapy modulates inflammatory response after traumatic brain injury. Brain Inj 17:1–10

  39. Narayanan R, Allen MR, Gaddy D et al (2004) Differential skeletal responses of hindlimb unloaded rats on a vitamin D-deficient diet to 1, 25-dihydroxyvitamin D3 and its analog, seocalcitol (EB1089). Bone 35:134–143

  40. Stein DG, Cekic MM (2011) Progesterone and vitamin d hormone as a biologic treatment of traumatic brain injury in the aged. PM R 3:S100–S110 

  41. Hua F, Reiss JI, Tang H, Wang J, Fowler X, Sayeed I, Stein DG (2012) Progesterone and low-dose vitamin D hormone treatment enhances sparing of memory following traumatic brain injury. Horm Behav 61(4):642–51

  42. Aminmansour B, Nikbakht H, Ghorbani A et al (2012) Comparison of the administration of progesterone versus progesterone and vitamin D in improvement of outcomes in patients with traumatic brain injury: a randomized clinical trial with placebo group. Adv Biomed Res 1:58

  43. Dziennis S, Akiyoshi K, Subramanian S (2011) Role of dihydrotestosterone in post-stroke peripheral immunosuppression after cerebral ischemia. Brain Behav Immun 25:685–695

  44. Zhang B, Subramanian S, Dziennis S et al (2010) Estradiol and G1 reduce infarct size and improve immunosuppression after experimental stroke. J Immunol 184:4087–4094

  45. Offner H, Subramanian S, Parker SM et al (2006a) Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages. J Immunol 176:6523–6231

  46. Lee JH, Ulrich B, Cho J, Park J, Kim CH (2011) Progesterone promotes differentiation of human cord blood fetal T cells into T regulatory cells but suppresses their differentiation into Th17 cells. J Immunol 187:1778–87

  47. Skrobot A, Demkow U, Wachowska M (2018) Immunomodulatory role of vitamin D: a review. Adv Exp Med Biol 1108:13–23

  48. Al Shoyaib A, Archie SR, Karamyan VT (2020) Intraperitoneal route of drug administration: should it be used in experimental animal studies? Pharm Res 37:12 

  49. Howard RB, Sayeed I, Stein DG (2017) Suboptimal dosing parameters as possible factors in the negative phase III clinical trials of progesterone for traumatic brain injury. J Neurotrauma 34(11):1915–1918

  50. Diamond TH, Ho KW, Rohl PG, et al (2005) Annual intramuscular injection of a megadose of cholecalciferol for treatment of vitamin D deficiency: efficacy and safety data. Med J Aust 183:10–12

  51. Longa EZ, Weinstein PR, Carlson S et al (1989) Reversible middle cerebral artery occlusion without craniectomy in rats 20:84–91

  52. Engel O, Meisel A (2010) Models of infection before and after stroke: investigating new targets. Infect Disord Drug Targets 10:98–104

  53. Dirnagl U, Klehmet J, Braun JS et al (2007) Stroke-induced immunodepression: experimental evidence and clinical relevance. Stroke 38:770–773

  54. Spencer SJ, Mouihate A, Pittman QJ (2007) Peripheral inflammation exacerbates damage after global ischemia independently of temperature and acute brain inflammation. Stroke 38:1570–1577

  55. Wasserstein RL, Schirm AL, Lazar NA (2019) Moving to a world beyond “p < 0.05”. Am Stat 73:1–19

  56. Eyles DW, Smith S, Kinobe R et al (2005) Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat 29:21–30 

  57. Stein DG (2017) Effects of sex steroids on damaged neural systems. In Pfaff DW, Joels M (eds) Hormones, brain and behavior. 3rd Edition. Oxford: Elseiver, 411–441

  58. Guennoun R, Zhu X, Fréchou M et al (2019) Steroids in Stroke with Special Reference to Progesterone. Cell Mol Neurobiol 39:551–568

  59. Evatt ML, DeLong MR, Khazai N et al (2008) Prevalence of vitamin D insufficiency in patients with Parkinson Disease and Alzheimer Disease. Arch Neurol 65:1348–1352

  60. Eyles DW, Burne TH, McGrath JJ (2013) Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease. Front Neuroendocrinol 34:47–64

  61. Aspell N, Brian Lawlor B, O’Sullivan M (2018) Is there a role for vitamin D in supporting cognitive function as we age? Proc Nutr Soc 77:124–134

  62. Janssen HC, Samson MM, Verhaar HJ (2002) Vitamin D deficiency, muscle function, and falls in elderly people. Am J Clin Nutr 75:611–615

  63. Moretti R, Morelli ME, Caruso P (2018) Vitamin D in neurological diseases: a rationale for a pathogenic impact. Int J Mol Sci 19:2245. https://doi.org/10.3390/ijms19082245

  64. Atif F, Prunty MC, Turan N et al (2017) Progesterone modulates diabetes/hyperglycemia-induced changes in the central nervous system and sciatic nerve. Neuroscience 350:1–12 

  65. Andrabi SS, Parvez S, Tabassum H (2017) Progesterone induces neuroprotection following reperfusion-promoted mitochondrial dysfunction after focal cerebral ischemia in rats. Dis Model Mech 10:787–796

  66. Espinosa-Garcia C, Sayeed I, Yousuf S et al (2017) Stress primes microglial polarization after global ischemia: therapeutic potential of progesterone. Brain Behav Immun 66:177–192

  67. Gaignard P, Fréchou M, SchumFacher M et al (2016) Progesterone reduces brain mitochondrial dysfunction after transient focal ischemia in male and female mice. J Cereb Blood Flow Metab 36:562–568

  68. Kim JY, Kawabori M, Yenari MA (2014) Innate inflammatory responses in stroke: mechanisms and potential therapeutic targets. Curr Med Chem 21:2076–2097

  69. Erickson MA, Banks BA (2018) Neuroimmune axes of the blood–brain barriers and blood–brain interfaces: bases for physiological regulation, disease states, and pharmacological interventions. Pharmacol Rev 70:278–314

  70. Spalletta G, Bossù P, Ciaramella A et al (2006) The etiology of poststroke depression: a review of the literature and a new hypothesis involving inflammatory cytokines. Mol Psychiatry 11:984–91

  71. Zaremba J, Losy J (2001) Early TNF‐α levels correlate with ischaemic stroke severity. 104:288–295

  72. Marcet P, Santos N, Borlongan CV (2017) When friend turns foe: central and peripheral neuroinflammation in central nervous system injury. Neuroimmunol Neuroinflamm 4:82–92

  73. Wang H, Chen W, Li D et al (2017) Vitamin D and chronic diseases. Aging Dis 8:346–353 

  74. Evans MA, Ki HA, Ling YH et al (2018) Supplementation reduces subsequent brain injury and inflammation associated with ischemic stroke. Neuromolecular Med 20:147–159

  75. Zhang Y, Leung, DY, Richers BN et al (2012) Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1. J Immunol 188:2127–2135

  76. Grudet C, Malm J, Westrin A et al (2014) Suicidal patients are deficient in vitamin D, associated with a pro-inflammatory status in the blood. Psychoneuroendocrinology 50:210–219

  77. Calton EK, Keane KN, Newsholme P et al (2015) The impact of vitamin D levels on inflammatory status: a systematic review of immune cell studies. PLoS ONE 10:e0141770 

  78. Fujimoto M, Nakano M, Terabe F et al (2011) The influence of excessive IL-6 production in vivo on the development and function of Foxp3+ regulatory T cells. J Immunol 186:32–40

  79. Chen ZQ, Mou RT, Feng DX et al (2017) The role of nitric oxide in stroke. Med Gas Res 7:194–203

  80. Wira CR, Rodriguez-Garcia M, Patel MV (2015) The role of sex hormones in immune protection of the female reproductive tract. Nat Rev Immunol 15:217–230

  81. Dumitrescu L, Popescu-Olaru I, Cozma L et al (2018) Oxidative stress and the microbiota-gut-brain axis. Oxid Med Cell Longev 2406594

  82. Sun MS, Jin H, Sun X et al (2018) Free radical damage in ischemia-reperfusion injury: an obstacle in acute ischemic stroke after revascularization therapy. Oxid Med Cell Longev 3804979. https://doi.org/10.1155/2018/3804979

  83. Chirumbolo S, Bjørklund G, Sboarina A et al (2017) The role of vitamin D in the immune system as a pro-survival molecule. Clin Ther 39:894–916

  84. Lan N, Luo G, Yang X et al (2014) 25-Hydroxyvitamin D3-deficiency enhances oxidative stress and corticosteroid resistance in severe asthma exacerbation. PLoS One 9:e111599

  85. Lima LAR, Lopes MJP, Costa RO et al (2018) Vitamin D protects dopaminergic neurons against neuroinflammation and oxidative stress in hemiparkinsonian rats. J Neuroinflammat 15:249

  86. Tarbali S, Khezri S (2016) Vitamin D3 attenuates oxidative stress and cognitive deficits in a model of toxic demyelination. Iran J Basic Med Sci 19:80–88

  87. Velimirović M, Jevtić Dožudić G et al (2018) Effects of vitamin D3 on the NADPH oxidase and matrix metalloproteinase 9 in an animal model of global cerebral ischemia. Oxid Med Cell Longev 3273654

  88. Quillinan N, Herson PS, Traystman RJ (2016) Neuropathophysiology of brain injury. Anesthesiol Clin 34:453–464

  89. Redza-Dutordoir M, Averill-Batesm DA (2016) Activation of apoptosis signalling pathways by reactive oxygen species. Biochimica et Biophysica Acta 1863:2977–2992

  90. Puttabyatappa M, Brogan RS, Vandevoot CA et al (2013) EGF-like ligands mediate progesterone’s anti-apoptotic action on macaque granulosa cells. Biol Reprod 88:18

  91. Theis V, Theis C (2019) Progesterone effects in the nervous system. Anat Rec (Hoboken) 5

  92. Turan N, Miller BA, Huie JR et al (2018) Effect of progesterone on cerebral vasospasm and neurobehavioral outcomes in a rodent model of subarchnoid hemorrhage. World Neurosurg 110:e150–e159

  93. Thatcher GR, Nicolescu AC, Bennett BM (2004) Nitrates and NO release: contemporary aspects in biological and medicinal chemistry. Free Rad Biol Med 37:1122–1143

  94. Solleiro-Villavicencio H, Rivas-Arancibia S (2018) Effect of chronic oxidative stress on neuroinflammatory respon`se mediated by CD4+T cells in neurodegenerative diseases. Front Cell Neurosci 12:114

  95. Zhang J, Han Y, Zhang J et al (2018) Neuronal nitric oxide synthase inhibition reduces brain damage by promoting collateral recruitment in a cerebral hypoxia-ischemia mice model. Eur Rev Med Pharmacol Sci 22:3166–3172

  96. Prentice H, Modi JP, Wu JY (2015) Mechanisms of neuronal protection against excitotoxicity, endoplasmic reticulum stress, and mitochondrial dysfunction in stroke and neurodegenerative diseases. Oxid Med Cell Longev 964518

  97. Xin Q, Ji B, Cheng B et al (2014) Endoplasmic reticulum stress in cerebral ischemia. Neurochem Int 68:18–27

  98. Lin YW, Chen TY, Hung CY et al (2018) Melatonin protects brain against ischemia/reperfusion injury by attenuating endoplasmic reticulum stress. Int J Mol Med 42:182–192

  99. Yuan YF, Das SK, Li MQ (2018) Vitamin D ameliorates impaired wound healing in streptozotocin-induced diabetic mice by suppressing endoplasmic reticulum stress. J Diabetes Res 1757925 

  100. Liu L, Zhang Y, Wang Y et al (2018) Progesterone inhibited endoplasmic reticulum stress associated apoptosis induced by interleukin-1β via the GRP78/PERK/CHOP pathway in BeWo cells. J Obstet Gynaecol Res 44:463–473 

  101. Stessman LE, Peeples ES (2018) Vitamin D and its role in neonatal hypoxic-ischemic brain injury. Neonatology 113:305–312

  102. Offner H, Subramanian S, Parker SM et al (2006b) Experimental stroke induces massive rapid activation of peripheral immune system. J Cereb Blood Flow Metab 26:654–665

  103. Medrano M, Carrillo-Cruz E, Montero I et al (2018) Vitamin D: effect on hematopoiesis and immune system and clinical applications. Int J Mol Sci 19:2663

  104. Van Etten E, Mathieu C (2005) Immunoregulation by 1, 25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol 97:93–101

  105. Benimetskaya L, Loike JD, Khaled Z et al (1997) Mac-1 (CD11b/CD18) is an oligodeoxynucleotide-binding protein. Nature Med 3:414–420

  106. Jämsä J, Huotari V, Savolainen ER et al (2015) Kinetics of leukocyte CD11b and CD64 expression in severe sepsis and non-infectious critical care patients. Acta Anaesthesiol Scand 59:881–891

  107. Veiga-Parga T (2016) Regulatory T cells and their role in animal disease. Vet Pathol 53(4):737–745

  108. Sakaguchi S, Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T (2009) Regulatory T cells: how do they suppress immune responses?. Int Immunol 21(10):1105–1111

Download references

Funding

The research was supported by gifts from Allen and Company and the Marcus Foundation. Allen and Company is a banking firm with no commercial interests in pharmacology or any other matters relating to our research. The Marcus Foundation is a philanthropic foundation supporting research in developmental psychobiology and other related areas.

Author information

Authors and Affiliations

Authors

Contributions

SY, FA: made a substantial contribution to the concept and design, acquisition of data or analysis and interpretation of data, drafted the article; CEG, NT: made a substantial contribution to the acquisition of data and interpretation of data, approved the version to be published; WH: acquisition of flow cytometric data or analysis and interpretation of data, approved the version to be published; DGS: made a substantial contribution to the concept and design, acquisition of data or analysis and revised it critically for important intellectual content, approved the version to be published.

Corresponding author

Correspondence to Seema Yousuf.

Ethics declarations

Disclaimer

The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Conflict of Interest

The authors declare no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yousuf, S., Atif, F., Espinosa-Garcia, C. et al. Stroke-Induced Peripheral Immune Dysfunction in Vitamin D–Deficient Conditions: Modulation by Progesterone and Vitamin D. Mol Neurobiol 58, 950–963 (2021). https://doi.org/10.1007/s12035-020-02129-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12035-020-02129-4

Keywords

Navigation